Profile data is unavailable for this security.
About the company
Fulgent Genetics, Inc. is a technology-based genetic company with a laboratory services business and a therapeutic development business. The Company’s laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its technology platform for its laboratory services business includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The platform provides a test menu, the ability to rapidly develop and launch new tests and customizable test offerings. The Company also offers next-generation sequencing (NGS) services.
- Revenue in USD (TTM)277.76m
- Net income in USD-164.97m
- Incorporated2016
- Employees1.18k
- LocationFulgent Genetics Inc4399 SANTA ANITA AVEEL MONTE 91731United StatesUSA
- Phone+1 (626) 350-0537
- Fax+1 (626) 454-1667
- Websitehttps://www.fulgentgenetics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accolade Inc | 441.03m | -80.10m | 298.79m | 2.40k | -- | 0.7048 | -- | 0.6775 | -1.03 | -1.03 | 5.69 | 5.26 | 0.5477 | -- | 17.46 | 183,761.70 | -9.95 | -24.80 | -11.44 | -29.04 | 48.24 | 45.56 | -18.16 | -56.43 | -- | -- | 0.3308 | -- | 14.09 | 34.30 | 78.29 | -- | 31.97 | -- |
| Viemed Healthcare Inc | 214.30m | 10.43m | 339.14m | 996.00 | 33.89 | 2.71 | 9.56 | 1.58 | 0.257 | 0.257 | 5.28 | 3.21 | 1.34 | 18.96 | 9.53 | 215,161.60 | 6.56 | 12.28 | 8.40 | 15.52 | 60.28 | 62.57 | 4.88 | 10.09 | 1.19 | 9.02 | 0.0489 | 0.00 | 31.82 | 23.21 | 64.63 | 1.50 | 33.67 | -- |
| Enhabit Inc | 1.04bn | -116.60m | 375.62m | 10.80k | -- | 0.6637 | -- | 0.3622 | -2.32 | -2.32 | 20.65 | 11.25 | 0.7529 | -- | 6.51 | 96,037.04 | -8.28 | -- | -9.49 | -- | 48.79 | -- | -11.00 | -- | -- | 0.6608 | 0.468 | -- | -2.32 | -- | -99.26 | -- | -- | -- |
| Airsculpt Technologies Inc | 188.78m | -7.79m | 390.47m | 346.00 | -- | 4.75 | 105.05 | 2.07 | -0.1373 | -0.1373 | 3.27 | 1.43 | 0.9156 | -- | 52.88 | 545,606.90 | -3.78 | -- | -4.24 | -- | 64.98 | -- | -4.13 | -- | -- | 1.98 | 0.4594 | -- | 16.07 | -- | 69.49 | -- | -- | -- |
| DocGo Inc | 694.97m | 30.83m | 420.45m | 2.92k | 14.51 | 1.29 | 9.10 | 0.605 | 0.284 | 0.284 | 6.41 | 3.19 | 1.52 | -- | 3.15 | 238,411.10 | 6.35 | -- | 8.97 | -- | 34.50 | -- | 4.17 | -- | -- | 61.05 | 0.1194 | -- | 41.72 | -- | -80.17 | -- | -- | -- |
| Sonida Senior Living Inc | 278.12m | -16.60m | 467.22m | 2.62k | -- | 6.03 | 19.66 | 1.68 | -2.13 | -2.13 | 22.48 | 6.75 | 0.3903 | -- | 26.74 | 106,272.50 | -1.64 | -6.63 | -1.90 | -8.19 | -- | -- | -4.20 | -18.04 | -- | -0.1916 | 0.8163 | -- | 7.08 | -11.11 | 55.74 | -- | -3.97 | -- |
| Fulgent Genetics Inc | 277.76m | -164.97m | 518.45m | 1.18k | -- | 0.4547 | -- | 1.87 | -5.53 | -5.53 | 9.25 | 37.28 | 0.2143 | -- | 5.21 | 234,595.40 | -13.27 | 16.70 | -14.00 | 18.37 | 36.22 | 67.89 | -61.91 | 29.06 | -- | -- | 0.0008 | 0.00 | -53.27 | 68.41 | -217.03 | -- | 57.08 | -- |
| Community Health Systems Inc | 12.55bn | -398.00m | 521.06m | 61.00k | -- | -- | 2.27 | 0.0415 | -3.00 | -3.00 | 95.32 | -13.12 | 0.8784 | 6.08 | 5.97 | 205,770.50 | -1.74 | 0.7566 | -2.15 | 0.9381 | 84.60 | 83.69 | -1.98 | 0.9345 | 1.32 | 0.9834 | 1.12 | -- | 2.28 | -2.47 | -389.13 | -- | -2.39 | -- |
| Talkspace Inc | 181.29m | -1.37m | 559.13m | 472.00 | -- | 4.75 | -- | 3.08 | -0.0085 | -0.0085 | 1.07 | 0.6965 | 1.30 | -- | 20.63 | 384,091.10 | -0.985 | -- | -1.15 | -- | 47.04 | -- | -0.7568 | -- | -- | -- | 0.00 | -- | 25.49 | -- | 75.92 | -- | -- | -- |
| InnovAge Holding Corp | 786.51m | -15.96m | 627.35m | 2.35k | -- | 2.40 | 279.94 | 0.7976 | -0.1175 | -0.1175 | 5.79 | 1.93 | 1.47 | -- | 17.30 | 334,686.00 | -3.35 | -3.72 | -4.76 | -4.90 | 17.64 | 20.39 | -2.28 | -2.79 | -- | -2.30 | 0.2172 | -- | 11.01 | 10.41 | 47.54 | -- | -11.39 | -- |
| Agilon Health Inc | 5.35bn | -306.78m | 733.39m | 1.12k | -- | 1.28 | -- | 0.137 | -0.7574 | -0.9521 | 13.13 | 1.40 | 2.45 | -- | 3.95 | 4,792,792.00 | -14.04 | -- | -36.97 | -- | 2.00 | -- | -5.73 | -- | -- | -- | 0.0572 | -- | 80.74 | -- | -112.01 | -- | -- | -- |
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2024 | 3.19m | 10.51% |
| The Vanguard Group, Inc.as of 30 Sep 2024 | 1.42m | 4.68% |
| Millennium Management LLCas of 30 Sep 2024 | 1.27m | 4.19% |
| Dimensional Fund Advisors LPas of 30 Sep 2024 | 1.04m | 3.45% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 793.55k | 2.62% |
| Park West Asset Management LLCas of 30 Sep 2024 | 713.58k | 2.36% |
| Geode Capital Management LLCas of 30 Sep 2024 | 502.87k | 1.66% |
| Columbia Management Investment Advisers LLCas of 30 Sep 2024 | 356.29k | 1.18% |
| Acadian Asset Management LLCas of 30 Sep 2024 | 300.58k | 0.99% |
| Citadel Advisors LLCas of 30 Sep 2024 | 298.91k | 0.99% |
